A carregar...

Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis

BACKGROUND: Tolvaptan has been approved in Japan for the treatment of hepatic edema. An important consideration in providing a clinical benefit to patients with liver cirrhosis is the improvement of ascites-related clinical symptoms. In the present post hoc analysis, we aimed to identify factors tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastroenterol
Main Authors: Sakaida, Isao, Terai, Shuji, Nakajima, Koji, Shibasaki, Yoshiyuki, Tachikawa, Sayaka, Tsubouchi, Hidetsugu
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5281662/
https://ncbi.nlm.nih.gov/pubmed/27379386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-016-1233-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!